Description

This comprehensive, three-day conference focuses on the latest research findings and their practical clinical applications for diagnosis, treatment and management of ADHD across the life span, as well as comorbidities such as substance use, mania, and more. Throughout the conference, benefit from direct, personal access to globally-recognized faculty from the Massachusetts General Hospital Department of Psychiatry, Harvard Medical School, and beyond.

Engage experts such as Drs. Joseph Biederman, Thomas Spencer, Timothy Wilens, and Janet Wozniak, ask your most pressing clinical questions about assessment and treatment of patients of all ages, and leave with guidance and solutions to the challenges you face every day in clinical practice.

Learning Objectives

At the end of this educational activity, participants should be able to:
  • Recognize the presentation, diagnosis, comorbidity, neurobiology, and current treatment options available for individuals with ADHD.
  • Review the presentation of ADHD across the life span; risk factors related to the persistence of the disorder and the neurobiology, heritability and genetic contributions of ADHD.
  • Differentiate common co-occurring conditions, such as learning disabilities, substance use, depressive and bipolar disorders, tic disorders, and anxiety.
  • Define effective psychotherapies, including family-based, individual, cognitive-behavioral, integrative, and multi-modal interventions.
  • Compare and contrast the pharmacological interventions for children, adolescents and adults with ADHD, including both stimulant and non-stimulant compounds.

Target Audience

The target audience for this event is psychiatrists, pediatricians, general and family practitioners, psychologists, nurses, social workers, and school-based clinicians.

Faculty

  • Pradeep G. Bhide, PhD
    Professor, Jim and Betty Ann Rodgers Eminent Scholar Chair of Developmental Neuroscience
    Director, Center for Brain Repair, Department of Biomedical Sciences, Florida State University College of Medicine
  • Joseph Biederman, MD
    Director, Pediatric Psychopharmacology Unit, Massachusetts General Hospital
    Professor of Psychiatry, Harvard Medical School
  • Barbara Coffey, MD, MS
    Associate Professor, Department of Child and Adolescent Psychiatry, NYU School of Medicine
    Director, Tics and Tourette’s Clinical and Research Program, NYU Child Study Center; Research Psychiatrist, Nathan Kline Institute for Psychiatric Research
  • Stephen V. Faraone, PhD
    Director, Medical Genetics Research, Director, Child and Adolescent Psychiatry Research
    Professor of Psychiatry and Neuroscience and Physiology, SUNY Upstate Medical University
  • Ronna Fried, PhD
    Co-Director of Neuropsychology in the Clinical and Research Programs in Pediatric Psychopharmacology and Adult ADHD, Massachusetts General Hospital
    Instructor in Psychology in the Department of Psychiatry, Harvard Medical School
  • Paul Hammerness, MD
    Scientific Coordinator, Pediatric ADHD Research, Clinical and Research Unit in Pediatric Psychopharmacology and Adult ADHD, Massachusetts General Hospital
    Assistant Professor in Psychiatry, Harvard Medical School
    Director, Child and Adolescent Psychiatry Clinic, Newton Wellesley Hospital
  • Aude Henin, PhD
    Co-Director, Child Cognitive-Behavioral Therapy Program, Massachusetts General Hospital
    Director, Cognitive Behavior Therapy Program, Clinical and Research Program in Pediatric Psychopharmacology, Massachusetts General Hospital
    Assistant Professor of Psychology in the Department of Psychiatry, Harvard Medical School
  • Michael S. Jellinek, MD
    Chief Clinical Officer, Partners HealthCare System
    Professor of Psychiatry and of Pediatrics, Harvard Medical School
  • Gagan Joshi, MD
    Director, Autism Spectrum Disorders Program
    Clinical & Research Program in Pediatric Psychopharmacology, Massachusetts General Hospital
    Assistant Professor of Psychiatry, Harvard Medical School
  • Jefferson B. Prince, MD
    Director of Child Psychiatry, North Shore Medical Center
    Staff, Child Psychiatry and Pediatric Psychopharmacology Clinics, Massachusetts General Hospital
    Instructor in Psychiatry, Harvard Medical School
  • Ronald Schouten, MD, JD
    Director, Law & Psychiatry Service, Massachusetts General Hospital
    Associate Professor of Psychiatry, Harvard Medical School
  • Bennett A. Shaywitz, MD
    The Charles and Helen Schwab Professor in Dyslexia and Learning Development, Yale Center for Dyslexia & Creativity
  • Sally E. Shaywitz, MD
    Co-Director, Yale Center for Dyslexia & Creativity
    The Audrey G. Ratner Professor in Learning Development in the Yale University School of Medicine
  • Thomas J. Spencer, MD
    Associate Chief, Pediatric Psychopharmacology Research Program, Massachusetts General Hospital
    Associate Professor of Psychiatry, Harvard Medical School
  • Craig Surman, MD
    Scientific Coordinator, Clinical and Research Programs in Pediatric Psychopharmacology and Adult ADHD, Massachusetts General Hospital
    Instructor in Psychiatry, Harvard Medical School
  • Eve Valera, PhD
    Research Associate, Massachusetts General Hospital
    Assistant Professor, Harvard Medical School
  • Timothy E. Wilens, MD
    Director, Substance Abuse Services in Pediatric Psychopharmacology, and Director, Center for Addiction Medicine, Massachusetts General Hospital
    Associate Professor of Psychiatry, Harvard Medical School
  • Janet Wozniak, MD
    Director, Pediatric Bipolar Disorder Clinical and Research Program, Massachusetts General Hospital
    Associate Professor of Psychiatry, Harvard Medical School

Pricing and Refunds

If you have a code from our direct mail brochure, you can save $25 off any of the rates listed here. We apologize for the misprinted rates on your brochure, the rates listed here are the most current and accurate.

Physicians /Psychologists
$695 ~ Early Bird Tuition before February 4, 2013 
$775 ~ Regular Tuition after February 4, 2013 

Nurses, Social Workers, other Allied HealthProfessionals 
$500 ~ Early Bird Tuition before February 4 2013 
$590 ~ Regular Tuition after February 4, 2013

An administrative fee of $100.00 will be deducted for cancellations. Refund requests must be received in writing no later than 10 business days prior to the course. No refunds will be made thereafter.

Agenda

Friday, March 15, 2013
  • 7:00-7:30am Registration and Continental Breakfast
  • 7:30-7:40 Introduction ~ Course Directors
  • 7:40-8:40 Definitions and Overview of ADHD ~ Joseph Biederman, MD
  • 8:40-9:25 Genetics of ADHD ~ Stephen V. Faraone, PhD
  • 9:25-9:40 Coffee Break
  • 9:40-10:40 Deficient Emotional Regulation in ADHD ~ Joseph Biederman, MD
  • 10:40-11:15 Population Management of ADHD in the Era of Healthcare Redesign ~ Michael Jellinek, MD
  • 11:15-12:15pm Mechanism of Action of Psychostimulants in Animal Models ~ Pradeep Bhide, PhD
  • 12:15-1:30 Lunch Break (On Your Own)
  • 1:30-2:30 Treatment of Pediatric ADHD with Stimulants ~ Thomas J. Spencer, MD
  • 2:30-3:30 Treatment of Pediatric ADHD with Non-Stimulants ~ Timothy E. Wilens, MD
  • 3:30-3:45 Coffee Break
  • 3:45-4:45 Late Onset and Atypical Forms of ADHD ~ Stephen V. Faraone, PhD
  • 4:45-5:30 Ask the Experts Panel Discussion/Question and Answer ~ Joseph Biederman, MD; Thomas J. Spencer, MD; Timothy E. Wilens, MD; Janet Wozniak, MD; and Moderator ~ Jefferson Prince, MD
  • 5:30-6:30 Dinner Break (On Your Own)
  • 6:30-7:30 Evening Seminars
  • 1. Management and Assessment of ADHD in College Students ~ Jefferson Prince, MD
  • 2. Management of the Complex Adult Patient with ADHD ~ Craig Surman, MD


Saturday, March 16, 2013
  • 7:30-8:00am Continental Breakfast
  • 8:00-9:00 ADHD and Mania ~ Janet Wozniak, MD
  • 9:00-10:00 Comorbidity of ADHD with Substance Abuse and Associated Risk Management Issues** ~ Timothy E. Wilens, MD
  • 10:00-10:15 Coffee Break
  • 10:15-11:15 CBT & Psychosocial Treatments in ADHD ~ Aude Henin, PhD
  • 11:15-12:15pm ADHD and Tourette's Disorder ~ Barbara J. Coffey, MD, MS
  • 12:15-1:45 Lunch Break (On Your Own)
  • 1:45-2:15 Driving and Working Impairments in ADHD ~ Ronna Fried, EdD
  • 2:15-2:45 Management of ADHD in the Context of Autism Spectrum Disorders ~ Gagan Joshi, MD
  • 2:45-3:00 Coffee Break
  • 3:00-3:45 Neuroimaging of ADHD ~ Eve Valera, PhD
  • 3:45-4:30 Diagnostic Assessment Approaches to Adult ADHD ~ Craig Surman, MD
  • 4:30-5:15 Cardiovascular Risk in the Management of ADHD** ~ Paul Hammerness, MD
  • 5:15-6:30 Dinner (On Your Own)
  • 6:30-7:30 Evening Seminars
  • 1. Perspectives on Proposed Changes for ADHD in DSM-V ~ Craig Surman, MD
  • 2. Educational Assessment and School Accommodations for Children and Adolescents with ADHD ~ Ronna Fried, EdD


Sunday, March 17, 2013
  • 7:30-8:00am Continental Breakfast
  • 8:00-9:00 Neuropsychology of ADHD ~ Ronna Fried, EdD
  • 9:00-10:00 Adult ADHD ~ Thomas J. Spencer, MD
  • 10:00-10:15 Coffee Break
  • 10:15-11:15 Pharmacology of Adults with ADHD ~ Thomas J. Spencer, MD
  • 11:15-12:15pm Neurobiology of Dyslexia ~ Bennett A. Shaywitz, MD; Sally E. Shaywitz, MD
  • 12:15-1:30 Lunch Break (On Your Own)
  • 1:30-2:30 Legal Issues in Treating Individuals with ADHD Disorders** ~ Ronald Schouten, MD, JD
  • 2:30 Adjourn

**Activities meet the criteria of theMassachusetts Board of Registration in Medicine for risk management study.

CME Information

Accreditation Statement
This activity has been planned and implemented in accordance with the Essential Areas and Policies of the Accreditation Council for Continuing Medical Education (ACCME) through the joint sponsorship of McLean Hospital and Massachusetts General Hospital. McLean Hospital is accredited by the ACCME to provide continuing medical education (CME) for physicians.

McLean Hospital designates this live activity for a maximum of 22.75 AMA PRA Category 1 Credit(s)TM. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

Psychologists: The Massachusetts General Hospital, Department of Psychiatry is approved by the American Psychological Association to offer Continuing Education (CE) for psychologists and maintains responsibility for this program.This offering meets the criteria for 22.75 Continuing Education (CE) credit per presentation for psychologists.

Nurses: This program meets the requirements of the Massachusetts Board of Registration in Nursing (244 CMR 5.00) for 22.75 contact hours of nursing continuing education credit. Advance practice nurses, please note: Educational activities which meet the requirements of the ACCME (such as this activity) count towards 50% of the nursing requirement for ANCC accreditation

Licensed Mental Health Counselor: This course has been certified by MMCEP and is approved as a Continuing Education course for Licensed Mental Health Counselors. The Certification Number is 12-0756. This course contains 22.75 hours of educational content.

Social Workers: This program has been approved for 22.75 Social Work Continuing Education hours forrelicensure, in accordance with 258 CMR. Collaborative of NASW and the Boston Collegeand Simmons Schools of Social Work Authorization Number D 60594.

Other CE Licenses: For information about continuing education credit for this course, call us at 866-644-7792.

Policy on Faculty and Provider Disclosure
It is the policy of McLean Hospital that faculty and providers disclose real or apparent conflicts of interest relating to the topics of this educational activity. McLean Hospital has established policies in place that identify and resolve all conflicts of interest prior to this educational activity.

Planner Disclosures

The following planners of this activity have indicated that neither they nor their spouse/partner have a relevant financial relationship to disclose:

John A. Fromson, MD: Reviewer

Tristan Gorrindo, MD

Anan Nathif, EdM

The following planner of this activity has indicated that he or a member of his immediate family has a significant financial interest or affiliation with the manufacturer of a commercial product or provider of a commercial service which may affect the content of this presentation. These disclosures may be germane to the content of the activity.

Joseph Biederman, MD

Dr. Joseph Biederman is currently receiving research support from the following sources: Elminda, Janssen, McNeil, and Shire.

In 2012, Dr. Joseph Biederman received an honorarium from the MGH Psychiatry Academy and The Children's Hospital of Southwest Florida/Lee Memorial Health System for tuition-funded CME courses.

In 2011, Dr. Joseph Biederman gave a single unpaid talk for Juste Pharmaceutical Spain, received honoraria from the MGH Pschiatry Academy for a tuition-funded CME course, and received honoraria for presenting at international scientific conference on ADHD. He also received an honorarium from Cambridge University Press for a chapter publication. Dr. Biederman received departmental royalties from a copyrighted rating scale used for ADHD diagnoses, paid by Eli Lilly, Shire and AstraZeneca; these royalties are paid to the Department of Psychiatry at MGH.

In 2010, Dr. Joseph Biederman received a speaker's fee from a single talk given at Funcadion Dr. Manuel A.C. in Monterry Mexico. Dr. Biederman provided single consultations for Shionogi Pharma Inc. and Cipher Pharmaceuticals Inc.; the honoraria for these consultations were paid to the Department of Psychiatry at the MGH. Dr. Biederman received honoraria from the MGH Psychiatry Academy for a tuition-funded CME course.

In previous years, Dr. Joseph Biederman received research support, consultation fees, or speaker's fees for/from the following additional sources: Abbott, Alza, AstraZeneca, Boston University, Bristol Myers Squibb, Celltech, Cephalon, Eli Lilly and Co.. Esai, Funcation Areces (Spain), Forest, Glaxo, Gliatech, Hastings Center, Janssen, McNeil, Medice Pharmaceuticals (Germany), Merck, MMC Pediatric, NARSAD, NIDA, New Rier, NICHD, NIMH, Novartis, Noven, Nuerosearch, Organon, Otsuka, Pfizer, Pharmacia, Phase V Communications, Physicians Academy, The Prechter Foundation, Quantia Communications, Reed Exhibitions, Shire, the Spanish Child Psychiatry Association, The Stanley Foundation, UCB Pharma Inc., Veritas, and Wyeth.

Thomas Spencer, MD

Research Support:

Shire Laboratories Inc, Cephalon, Eli Lilly & Company, Glaxo-Smith Kline, Janssen, McNeil Pharmaceutical, Novartis Pharmaceuticals, Pfizer, NIMH and the Department of Defense. 

Speaking: 

Shire Laboratories, Inc, Eli Lilly & Company, Glaxo-Smith Kline, Janssen, McNeil Pharmaceutical, Novartis Pharmaceuticals. 

Advisory Board:

Alcobra, Shire Laboratories Inc, Cephalon, Eli Lilly & Company, Glaxo-Smith Kline, Janssen, McNeil Pharmaceutical, Novartis Pharmaceuticals, and Pfizer.

Dr. 
Spencer has a US Patent Application pending (Provisional Number 
61/233,686), through MGH corporate licensing, on a method to prevent stimulant abuse.

Timothy E. Wilens, MD

Research Support:
Abbott, McNeil, Eli Lilly & Co., NIH (NIDA), Merck, and Shire.

Speaker/Honoraria:

McNeil, Eli Lilly & Co., Shire, and Novartis.

Advisory/Consulting:

Abbott, McNeil, Eli Lilly & Co., NIH (NIDA), Merck, Shire, and Novartis

We are committed to giving learners the most comprehensive view of disclosure information. For this reason, in addition to listing the disclosures specific to this activity, we also maintain a database of global disclosures for all faculty who plan or speak at our activities. Biographical information for each facutly is also included. To view a specific speaker or planner’s global disclosure, please click on theappropriate link below.

Pradeep G. Bhide, PhD

Joseph Biederman, MD

Barbara Coffey, MD, MS

Stephen V. Faraone, PhD

Ronna Fried, PhD

Paul Hammerness, MD

Aude Henin, PhD

Michael S. Jellinek, MD

Gagan Joshi, MD

Jefferson B. Prince, MD

Ronald Schouten, MD, JD

Bennett A. Shaywitz, MD

Sally E. Shaywitz, MD

Thomas J. Spencer, MD

Craig Surman, MD

Eve Valera, PhD

Timothy E. Wilens, MD

Janet Wozniak, MD

Privacy Policy:

Please click here to review our privacy policy.



Location

The Charles Hotel, 1 Bennett Street, Cambridge, MA 02138, USA